Cingulate will use the money — delivered in three $1 million tranches — to help develop its third drug, which targets an $11.6 billion global market. Cingulate Inc. received a pledge for $3 ...

US biopharmaceutical company Cingulate has announced the receipt of a $3m grant from a private foundation to expedite the development of a once-daily formulation of buspirone, CTx-2103 ...

KANSAS CITY, Kan., April 09, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery ...

KANSAS CITY, Kan., April 09, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...

April 09, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

Gyrus Capital has agreed to buy a majority stake in ACBC. Co-founders Gio Giacobbe and Edoardo Iannuzzi and the existing management team have made a significant reinvestment in the company ...

Diabetes is known to cause many medical issues, from heart disease to vision problems — and now a new study suggests it could also impact memory and other cognitive functions. After observing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The content creator claims that a chiropractor herniated a disc when forcefully cracking his neck, and now his life savings has "evaporated" from medical bills Tyler Williams/Instagram Popular ...